Speaker Profile
PHARMD, Global Stakeholder Relations Lead, Oncology, Sanofi
Biography
Dr. Krupa Paranjpe is a distinguished leader in oncology with expertise in global stakeholder engagement, medical affairs strategy, and clinical innovation. As the Global Stakeholder Relations Lead at Sanofi Oncology, she plays a pivotal role in shaping collaborative strategies that address health system barriers, evolve oncology endpoints, and advance diagnostic approaches such as minimal residual disease (MRD) testing.With a strong focus on improving patient outcomes, Dr. Paranjpe drives initiatives that bridge clinical research, diagnostics, and real-world application. Her experience spans impactful programs such as the OncoCollective Initiative, where she has championed innovative solutions to meet the unmet needs in cancer care.Dr. Paranjpe earned her Doctor of Pharmacy (Pharm.D.) degree and has since built a career dedicated to addressing critical challenges in oncology through collaboration and innovation.
Talk
Key Points: -Transformational importance of evolving endpoints in oncology-MRD in Multiple Myeloma-A collective of multi-disciplinary oncology experts focus on addressing Health System barriers in adoption of MRD as an endpoint-Educationawareness for all stakeholders in ecosystem: Patients, Providers, payers, regulators
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony:
Luminary Honoree: Hedvig Hricak, Memorial Sloan Kettering
Pioneer Honoree: Michael E. Phelps, UCLA - Keynote: Precision Imaging for Precision Medicine
- Hedvig Hricak, Memorial Sloan Kettering
- Keynote: PET Imaging and Theranostics: Revolutionizing Cancer Detection and Treatment
- Michael E. Phelps, UCLA
- Radiopharmaceuticals for Cancer Therapy (PANEL)
Chair: Wiliam Oh, Yale Caner Center
- Naga Vara Kishore Pillarsetty, Memorial Sloan Kettering
- Jones Nauseef, Convergent Therapeutics
- Thomas Hope, UCSF
- Advancements in Digital Imaging: Enhancing Accuracy in Cancer Diagnostics
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Hedvig Hricak, Memorial Sloan Kettering
- Eliot Siegel, VA Maryland Healthcare System
- Sharmila Majumdar, UCSF
- Wafik El-Deiry, Brown University - Digitalizing Oncology Care: Challenges and Opportunities (PANEL)
Chair: Christian Wolfrum, Siemens Healthineers
- Ashley Smith, Varian
- Marshall Pitz, Manitoba Cancer Care
- Measuring Tumor Aggressiveness: How Nanotechnology is Shaping the Future of Cancer Diagnostics
- Marija Plodinec, ARTIDIS
- Alastair Thompson, Baylor College of Medicine
- Stacey Tinianov, Advocates for Collaborative Education
- Overcoming Health System Barriers and Redefining Oncology Endpoints: The Role of MRD
- Krupa Paranjpe, Sanofi - Unlocking MRD Testing and Beyond: Combining Ultra-High Sensitivity WGS with Low Cost
- Gilad Almogy, Ultima Genomics - Ultra-Rapid NGS Testing: Why Time Matters
- Luca Quagliata, ThermoFisher
- Ibiayi Dagogo-Jack, Massachusetts General Hospital
- PMWC Showcase
- Tuvik Beker, Pangea Biomed
- Navigating Regulatory Hurdles and Reimbursement Pathways for Oncology Innovations
Chair: Sheila Walcoff, Goldbug Strategies
- Wui-Jin Koh, NCCN - Gabriel A. Bien-Willner, Palmetto GBA
- Erin Satterwhite, Optum Specialty Pharmacy
